Position in KROS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,476,460
-$130,665 QoQ
Shares Held
137,987
-5.2% QoQ
Ownership
0.696%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#31
of 132 holders
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KROS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. KROS ranks #237 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,450,825 | $1,020,369,609 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
17,466,641 | $618,144,423 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
3,399,221 | $416,676,508 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
712,259 | $353,800,411 | |
| 5 | MRNA |
Moderna, Inc.
|
4,463,211 | $312,558,664 | |
| 6 | INSM |
INSMED Inc
|
2,584,446 | $275,553,630 | |
| 7 | ABVX |
Abivax S.A.
|
1,844,918 | $245,853,771 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
401,708 | $215,697,109 |
All Filings in KROS
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,476,460 | 137,987 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $1,607,125 | 145,573 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $1,976,629 | 97,084 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $1,643,128 | 103,864 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,372,019 | 102,773 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $941,851 | 92,429 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $2,769,316 | 174,941 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,246,519 | 55,907 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,995,863 | 65,555 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $8,221,046 | 124,185 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $7,211,867 | 181,385 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $209,993 | 6,587 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $1,193,988 | 29,716 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $1,411,277 | 33,051 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,361,574 | 49,179 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $6,141,051 | 163,239 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $5,440,760 | 196,915 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $10,858,761 | 199,683 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $9,105,033 | 155,615 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $5,134,175 | 129,782 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $60,307 | 1,420 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $958,148 | 15,567 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $17,564 | 249 | Shares | Sole | 2021-02-11 | |
| 2020-06-30 | $82,784 | 2,207 | Shares | Sole | 2020-07-31 | |
| No filing history on record for this holder in this stock. | ||||||